Bio-Techne (TECH) Long-Term Debt Issuances (2014 - 2025)
Bio-Techne's quarterly Long-Term Debt Issuances came in at $66.0 million in Q2 2025, up 73.68% quarter-over-quarter from $38.0 million in Q1 2025.
Bio-Techne has reported Long-Term Debt Issuances for 10 years, with the latest figure at $66.0 million in Q2 2025.
- For the quarter ending Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to $66.0 million; the trailing twelve-month figure through Jun 2025 stood at $104.0 million (down 53.78% YoY), and the FY2025 full-year result was $104.0 million, down 53.78% from the prior year.
- Long-Term Debt Issuances for Q2 2025 stood at $66.0 million, up from $38.0 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $449.7 million in Q3 2022, with the low at $10.0 million in Q3 2021.
- Average Long-Term Debt Issuances over 4 years is $129.5 million, with a median of $65.5 million recorded in 2023.
- Year-over-year, Long-Term Debt Issuances surged 4396.61% in 2022 and plunged 64.42% in 2023.
- Tracing TECH's Long-Term Debt Issuances over 4 years: stood at $40.0 million in 2021, then surged by 1024.15% to $449.7 million in 2022, then sank by 85.54% to $65.0 million in 2023, then advanced by 1.54% to $66.0 million in 2025.
- The last three Long-Term Debt Issuances figures came in at $66.0 million (Q2 2025), $38.0 million (Q1 2025), and $65.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 66.00 Mn |
| Jun 30, 2025 | 66.00 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Dec 31, 2023 | 65.00 Mn |
| Dec 31, 2023 | 65.00 Mn |
| Sep 30, 2023 | 160.00 Mn |
| Sep 30, 2023 | 160.00 Mn |
| Mar 31, 2023 | 170.00 Mn |
| Mar 31, 2023 | 170.00 Mn |
| Sep 30, 2022 | 449.66 Mn |
| Sep 30, 2022 | 449.66 Mn |
| Mar 31, 2022 | 40.00 Mn |
| Mar 31, 2022 | 40.00 Mn |
| Dec 31, 2021 | 40.00 Mn |
| Dec 31, 2021 | 40.00 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 256.00 Mn |
| Jun 30, 2021 | 256.00 Mn |
| Mar 31, 2020 | 40.00 Mn |
| Mar 31, 2020 | 40.00 Mn |
| Sep 30, 2018 | 580.00 Mn |
| Sep 30, 2018 | 580.00 Mn |
| Mar 31, 2018 | 30.00 Mn |
| Mar 31, 2018 | 30.00 Mn |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | 24.91 Mn |
| Dec 31, 2016 | 24.91 Mn |
| Sep 30, 2016 | 343.50 Mn |
| Sep 30, 2016 | 343.50 Mn |
| Sep 30, 2015 | 77.00 Mn |
| Sep 30, 2015 | 77.00 Mn |
| Dec 31, 2014 | 38.00 Mn |
| Dec 31, 2014 | 38.00 Mn |
| Sep 30, 2014 | 125.00 Mn |
| Sep 30, 2014 | 125.00 Mn |